Webinar: Diabetes treatment trials and tribulations: Overcoming therapeutic inertia
- : Online
How can we encourage our patients to reach and maintain optimal glycaemic control in type 2 diabetes (T2D)? Often we need to rationalise what’s not working to be able to choose solutions that will work.
By understanding the phases and characteristics of diabetes therapeutic inertia, you will be able to identify where the road blocks are happening – whether it is your patient’s psychological insulin resistance, your own understandable concern about hypoglycaemia or a missing link in the multidisciplinary team.
Join this lively, interactive webinar, led by distinguished international and national experts and learn evidence-based solutions for diabetes treatment inertia to help you and your patients overcome this tricky issue!
- Professor Kamlesh Khunti MD PhD FRCP FRCGP FMedSci
- Dr Gary Deed MBBS FACNEM MRACGP
- Margaret McGill AM
By completing this learning activity, participants will be able to:
- Discuss the positive effect of early glycaemic control on patient outcomes in type 2 diabetes
- Identify the causes of therapeutic inertia in diabetes management
- Rationalise the phases and characteristics of insulin inertia, including initiation, titration and intensification
- Apply practical, evidence-based strategies to overcome therapeutic inertia in the Australian primary practice setting, including the role of new generation, co-formulation insulins